Celeste Richardson

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for immunooncology
- Patent number 12,037,583
- Issue date Jul 16, 2024
- Novartis AG
- Ming-Wei Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PDE5 compositions and methods for immunotherapy
- Patent number 11,666,642
- Issue date Jun 6, 2023
- Obsidian Therapeutics, Inc.
- Vipin Suri
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PDE5 compositions and methods for immunotherapy
- Patent number 11,241,485
- Issue date Feb 8, 2022
- Obsidian Therapeutics, Inc.
- Vipin Suri
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CA2 compositions and methods for tunable regulation
- Patent number 11,058,725
- Issue date Jul 13, 2021
- Obsidian Therapeutics, Inc.
- Kutlu Goksu Elpek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 10,851,166
- Issue date Dec 1, 2020
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 9,777,061
- Issue date Oct 3, 2017
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20240417722
- Publication date Dec 19, 2024
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED IMMUNE CELL THERAPEUTICS AND METHODS OF USE
- Publication number 20240156867
- Publication date May 16, 2024
- Catamaran Bio, Inc.
- Jared Allan Sewell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR EXPANSION OF T CELLS AND TUMOR INFILTR...
- Publication number 20240075064
- Publication date Mar 7, 2024
- Obsidian Therapeutics, Inc.
- Kutlu Goksu Elpek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
- Publication number 20230092895
- Publication date Mar 23, 2023
- Obsidian Therapeutics, Inc.
- Vipin Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
- Publication number 20230074330
- Publication date Mar 9, 2023
- Obsidian Therapeutics, Inc.
- Vipin SURI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY MODIFIED NATURAL KILLER CELLS AND METHODS OF USE THEREOF
- Publication number 20230051406
- Publication date Feb 16, 2023
- Catamaran Bio, Inc.
- Vipin SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
- Publication number 20230026259
- Publication date Jan 26, 2023
- Obsidian Therapeutics, Inc.
- Vipin SURI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PDE5 DERIVED REGULATORY CONSTRUCTS AND METHODS OF USE IN IMMUNOTHERAPY
- Publication number 20220403001
- Publication date Dec 22, 2022
- Obsidian Therapeutics, Inc.
- Vipin SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION
- Publication number 20220332780
- Publication date Oct 20, 2022
- Obsidian Therapeutics, Inc.
- Kutlu Goksu ELPEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD40L COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
- Publication number 20220175781
- Publication date Jun 9, 2022
- Obsidian Therapeutics, Inc.
- Michael SCHEBESTA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR THERAPEUTICS ENGINEERED WITH SIGNAL MODULATORS AND METHODS...
- Publication number 20220162288
- Publication date May 26, 2022
- Catamaran Bio, Inc.
- Celeste Richardson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ER TUNABLE PROTEIN REGULATION
- Publication number 20210386788
- Publication date Dec 16, 2021
- Obsidian Therapeutics, Inc.
- Vipin SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210139595
- Publication date May 13, 2021
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
- Publication number 20210069248
- Publication date Mar 11, 2021
- Obsidian Therapeutics, Inc.
- Kutlu Goksu ELPEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
- Publication number 20200101142
- Publication date Apr 2, 2020
- Obsidian Therapeutics, Inc.
- Vipin SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20180362975
- Publication date Dec 20, 2018
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180044423
- Publication date Feb 15, 2018
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160096892
- Publication date Apr 7, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20160046724
- Publication date Feb 18, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Celeste Richardson

Person

Patents Grantslast 30 patents

Compositions and methods for immunooncology

PDE5 compositions and methods for immunotherapy

PDE5 compositions and methods for immunotherapy

Anti-BCMA chimeric antigen receptor

CA2 compositions and methods for tunable regulation

Treatment of cancer using a CD33 chimeric antigen receptor

Treatment of cancer using a CLL-1 chimeric antigen receptor

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Treatment of cancer using a CD33 chimeric antigen receptor

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

ENGINEERED IMMUNE CELL THERAPEUTICS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR EXPANSION OF T CELLS AND TUMOR INFILTR...

TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

GENETICALLY MODIFIED NATURAL KILLER CELLS AND METHODS OF USE THEREOF

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

PDE5 DERIVED REGULATORY CONSTRUCTS AND METHODS OF USE IN IMMUNOTHERAPY

CA2-IL15 FUSION PROTEINS FOR TUNABLE REGULATION

CD40L COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

CELLULAR THERAPEUTICS ENGINEERED WITH SIGNAL MODULATORS AND METHODS...

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

ER TUNABLE PROTEIN REGULATION

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...